Research ExplorerPublicationsEntecavir plus tenofovir combination as rescue therapy in pr...

Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.

Standard

Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. / Petersen, Jorg; Ratziu, Vlad; Buti, Maria; Janssen, Harry L A; Brown, Ashley; Lampertico, Pietro; Schollmeyer, Jan; Zoulim, Fabien; Wedemeyer, Heiner; Sterneck, Martina; Berg, Thomas; Sarrazin, Christoph; Lütgehetmann, Marc; Buggisch, Peter.

In: J HEPATOL, Vol. 56, No. 3, 3, 01.03.2012, p. 520-526.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Petersen, J, Ratziu, V, Buti, M, Janssen, HLA, Brown, A, Lampertico, P, Schollmeyer, J, Zoulim, F, Wedemeyer, H, Sterneck, M, Berg, T, Sarrazin, C, Lütgehetmann, M & Buggisch, P 2012, 'Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.', J HEPATOL, vol. 56, no. 3, 3, pp. 520-526. https://doi.org/10.1016/j.jhep.2011.09.018

APA

Petersen, J., Ratziu, V., Buti, M., Janssen, H. L. A., Brown, A., Lampertico, P., Schollmeyer, J., Zoulim, F., Wedemeyer, H., Sterneck, M., Berg, T., Sarrazin, C., Lütgehetmann, M., & Buggisch, P. (2012). Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J HEPATOL, 56(3), 520-526. [3]. https://doi.org/10.1016/j.jhep.2011.09.018

Vancouver

Petersen J, Ratziu V, Buti M, Janssen HLA, Brown A, Lampertico P et al. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J HEPATOL. 2012 Mar 1;56(3):520-526. 3. https://doi.org/10.1016/j.jhep.2011.09.018

Bibtex

@article{7251bdfd14514e7c95fc7dc175a9f6b0,
title = "Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.",
abstract = "Long-term viral suppression is a major goal to prevent disease progression in patients with HBV. Aim of this study was to investigate the efficacy and safety of entecavir plus tenofovir combination in 57 CHB partial responders or multidrug resistant patients.",
keywords = "Adenine, Adult, Aged, Antiviral Agents, Cohort Studies, Drug Resistance, Viral, Drug Therapy, Combination, Female, Follow-Up Studies, Guanine, Hepatitis B, Chronic, Humans, Internationality, Male, Middle Aged, Organophosphonates, Retrospective Studies, Treatment Outcome, Viremia, Young Adult",
author = "Jorg Petersen and Vlad Ratziu and Maria Buti and Janssen, {Harry L A} and Ashley Brown and Pietro Lampertico and Jan Schollmeyer and Fabien Zoulim and Heiner Wedemeyer and Martina Sterneck and Thomas Berg and Christoph Sarrazin and Marc L{\"u}tgehetmann and Peter Buggisch",
note = "Copyright {\textcopyright} 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.",
year = "2012",
month = mar,
day = "1",
doi = "10.1016/j.jhep.2011.09.018",
language = "English",
volume = "56",
pages = "520--526",
journal = "J HEPATOL",
issn = "0168-8278",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study.

AU - Petersen, Jorg

AU - Ratziu, Vlad

AU - Buti, Maria

AU - Janssen, Harry L A

AU - Brown, Ashley

AU - Lampertico, Pietro

AU - Schollmeyer, Jan

AU - Zoulim, Fabien

AU - Wedemeyer, Heiner

AU - Sterneck, Martina

AU - Berg, Thomas

AU - Sarrazin, Christoph

AU - Lütgehetmann, Marc

AU - Buggisch, Peter

N1 - Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Long-term viral suppression is a major goal to prevent disease progression in patients with HBV. Aim of this study was to investigate the efficacy and safety of entecavir plus tenofovir combination in 57 CHB partial responders or multidrug resistant patients.

AB - Long-term viral suppression is a major goal to prevent disease progression in patients with HBV. Aim of this study was to investigate the efficacy and safety of entecavir plus tenofovir combination in 57 CHB partial responders or multidrug resistant patients.

KW - Adenine

KW - Adult

KW - Aged

KW - Antiviral Agents

KW - Cohort Studies

KW - Drug Resistance, Viral

KW - Drug Therapy, Combination

KW - Female

KW - Follow-Up Studies

KW - Guanine

KW - Hepatitis B, Chronic

KW - Humans

KW - Internationality

KW - Male

KW - Middle Aged

KW - Organophosphonates

KW - Retrospective Studies

KW - Treatment Outcome

KW - Viremia

KW - Young Adult

U2 - 10.1016/j.jhep.2011.09.018

DO - 10.1016/j.jhep.2011.09.018

M3 - SCORING: Journal article

C2 - 22037226

VL - 56

SP - 520

EP - 526

JO - J HEPATOL

JF - J HEPATOL

SN - 0168-8278

IS - 3

M1 - 3

ER -